Carbohydrate metabolism in cardiovascular disease

Area of Science:

• Biochemistry
• Cardiology
• Metabolic Disorders

Background:

• Acute myocardial infarction (AMI) causes temporary disturbances in carbohydrate metabolism.
• Hyperglycemia and impaired insulin response in AMI correlate with infarction severity.
• Hormonal changes, including increased catecholamines and glucagon, accompany AMI.

Purpose of the Study:

• To explore the metabolic alterations in myocardial infarction and peripheral vascular disease.
• To understand the role of glucose and free fatty acid (FFA) metabolism in ischemic heart tissue.
• To investigate the potential mechanisms linking glucose intolerance and arterial lesions in peripheral vascular disease.

Main Methods:

• Analysis of metabolic and hormonal changes during myocardial infarction.
• Evaluation of the impact of glucose and FFA metabolism on infarcting cardiac tissue.
• Examination of glucose intolerance and its association with arterial lesions in peripheral vascular disease.

Main Results:

• Infarcting tissue exhibits complex glucose metabolism, with FFA uptake inhibiting mitochondrial function.
• High circulating FFA and glucose intolerance are detrimental to ischemic heart tissue.
• Experimental interventions like dichloroacetate and nicotinic acid analogues reduced infarct size; glucose-insulin-potassium and propranolol increased glucose uptake while decreasing FFA uptake.

Conclusions:

• The metabolic response to AMI, characterized by glucose intolerance and elevated FFA, is harmful to ischemic cardiac tissue.
• Altered insulin concentrations in peripheral vascular disease may contribute to arterial lesion development.
• Peripheral vascular disease may involve a multi-hormonal disorder contributing to arteriosclerosis.